Anders Sundín

2.0k total citations · 1 hit paper
30 papers, 1.4k citations indexed

About

Anders Sundín is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology and Neurology. According to data from OpenAlex, Anders Sundín has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Epidemiology and 12 papers in Neurology. Recurrent topics in Anders Sundín's work include Neuroendocrine Tumor Research Advances (13 papers), Medical Imaging Techniques and Applications (12 papers) and Neuroblastoma Research and Treatments (11 papers). Anders Sundín is often cited by papers focused on Neuroendocrine Tumor Research Advances (13 papers), Medical Imaging Techniques and Applications (12 papers) and Neuroblastoma Research and Treatments (11 papers). Anders Sundín collaborates with scholars based in Sweden, United Kingdom and United States. Anders Sundín's co-authors include Mats Bergström, Gianfranco Delle Fave, Philippe Ruszniewski, Piero Ferollà, Tetsuhide Ito, Diego Ferone, Wouter W. de Herder, Babs G. Taal, John Ramage and Wolfgang Weber and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Medical Physics.

In The Last Decade

Anders Sundín

30 papers receiving 1.4k citations

Hit Papers

ENETS Consensus Guidelines Update for Gastroduodenal Neur... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
    2016 330 citations Gianfranco Delle Fave, Dermot O’Toole et al. Neuroendocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Sundín Sweden 16 786 708 512 313 216 30 1.4k
Franca Chierichetti Italy 20 346 0.4× 703 1.0× 292 0.6× 461 1.5× 32 0.1× 73 1.7k
G. Ferlin Italy 18 219 0.3× 266 0.4× 264 0.5× 228 0.7× 14 0.1× 53 1.2k
J. F. Henry France 20 180 0.2× 233 0.3× 118 0.2× 932 3.0× 19 0.1× 52 1.7k
Pascal Maisonobe France 21 253 0.3× 157 0.2× 898 1.8× 292 0.9× 12 0.1× 87 1.6k
Masahiro Tsubaki Japan 18 169 0.2× 148 0.2× 218 0.4× 194 0.6× 72 0.3× 52 923
Alby Elias United States 19 67 0.1× 522 0.7× 105 0.2× 116 0.4× 18 0.1× 38 1.2k
A. Keyser Netherlands 20 137 0.2× 171 0.2× 174 0.3× 302 1.0× 7 0.0× 59 1.5k
László Pávics Hungary 14 92 0.1× 76 0.1× 96 0.2× 137 0.4× 59 0.3× 71 676
Zhong Ju China 19 397 0.5× 62 0.1× 173 0.3× 56 0.2× 19 0.1× 77 1.1k
Tadayuki Maehara Japan 19 336 0.4× 108 0.2× 208 0.4× 314 1.0× 4 0.0× 57 1.1k

Countries citing papers authored by Anders Sundín

Since Specialization
Citations

This map shows the geographic impact of Anders Sundín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Sundín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Sundín more than expected).

Fields of papers citing papers by Anders Sundín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Sundín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Sundín. The network helps show where Anders Sundín may publish in the future.

Co-authorship network of co-authors of Anders Sundín

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Sundín. A scholar is included among the top collaborators of Anders Sundín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Sundín. Anders Sundín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Botling, Johan, Britt Skogseid, Barbro Eriksson, et al.. (2025). The impact of re‐characterizing metastatic pancreatic neuroendocrine tumors: A prospective study. Journal of Neuroendocrinology. 37(8). e70040–e70040. 2 indexed citations
2.
3.
Gillett, Daniel, Russell Senanayake, James MacFarlane, et al.. (2025). A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism. Journal of Nuclear Medicine. 66(3). 434–440. 3 indexed citations
4.
Fave, Gianfranco Delle, Dermot O’Toole, Anders Sundín, et al.. (2016). ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Neuroendocrinology. 103(2). 119–124. 330 indexed citations breakdown →
5.
Sandström, Mattias, Ulrike Garske‐Román, Donald Granberg, Anders Sundín, & Mark Lubberink. (2015). Fractional contribution of extrapolations after 96 h in absorbed dose calculation to kidneys in 450 patients with neuroendocrine tumours receiving Lu-177-DOTATATE therapy. European Journal of Nuclear Medicine and Molecular Imaging. 42. 1 indexed citations
6.
Hahner, Stefanie & Anders Sundín. (2011). Metomidate-Based Imaging of Adrenal Masses. Hormones and Cancer. 2(6). 348–353. 24 indexed citations
7.
Hennings, Joakim, Anders Sundín, Anders Hägg, & Per Hellman. (2010). 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism. Langenbeck s Archives of Surgery. 395(7). 963–967. 32 indexed citations
8.
Skorpil, Mikael, Tyler Rolheiser, H.A. Robertson, Anders Sundín, & Per Svenningsson. (2010). Diffusion tensor fiber tractography of the olfactory tract. Magnetic Resonance Imaging. 29(2). 289–292. 22 indexed citations
9.
Thomas, Dimitrios, et al.. (2010). The value of 11C-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center. Journal of Endocrinological Investigation. 33(11). 794–799. 12 indexed citations
10.
Eriksson, B., Håkan Örlefors, Kjell Öberg, et al.. (2005). Developments in PET for the detection of endocrine tumours. Best Practice & Research Clinical Endocrinology & Metabolism. 19(2). 311–324. 65 indexed citations
11.
Örlefors, Håkan, Anders Sundín, K. Öberg, et al.. (2005). Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 33(1). 60–65. 63 indexed citations
12.
Örlefors, Håkan, Anders Sundín, K. Öberg, et al.. (2003). Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo–tumor visualization using positron emission tomography with 11C-harmine. Nuclear Medicine and Biology. 30(6). 669–679. 30 indexed citations
13.
Lövqvist, Anna, Hans Lundqvist, Mark Lubberink, et al.. (1999). Kinetics of ‐labeled anti‐CEA antibodies in pigs; Aspects of dosimetry and PET imaging properties. Medical Physics. 26(2). 249–258. 20 indexed citations
14.
Edgren, M, J E Westlin, Karl Mikael Kälkner, Anders Sundín, & S. Nilsson. (1999). [ 111 In-DPTA-D-Phe 1 ] - Octreotide Scintigraphy in the Management of Patients with Advanced Renal Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 14(1). 59–64. 24 indexed citations
15.
Örlefors, Håkan, Anders Sundín, Anders Lilja, et al.. (1998). Positron emission tomography (PET) with 5-hydroxytryptophan (5-HTP) in the diagnosis and treatment follow upp of carcinoid tumors. Journal of Clinical Oncology. 7. 2534. 10 indexed citations
16.
Örlefors, Håkan, Anders Sundín, Håkan Åhlström, et al.. (1998). Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors.. Journal of Clinical Oncology. 16(7). 2534–2541. 112 indexed citations
17.
Åhlström, Håkan, et al.. (1997). [18F] FDG PET in Gastric Non-Hodgkin's Lymphoma. Acta Oncologica. 36(6). 577–584. 28 indexed citations
18.
Aziz, Qasim, S. Valind, Anders Sundín, et al.. (1997). Identification of human brain loci processing esophageal sensation using positron emission tomography. Gastroenterology. 113(1). 50–59. 221 indexed citations
19.
Sundín, Anders, Claes Johansson, Per Hellman, et al.. (1996). PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism.. PubMed. 37(11). 1766–70. 78 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franca Chierichetti Breakdown of academic impact, for papers by G. Ferlin Breakdown of academic impact, for papers by J. F. Henry Breakdown of academic impact, for papers by Pascal Maisonobe Breakdown of academic impact, for papers by Masahiro Tsubaki Breakdown of academic impact, for papers by Alby Elias Breakdown of academic impact, for papers by A. Keyser Breakdown of academic impact, for papers by László Pávics Breakdown of academic impact, for papers by Zhong Ju Breakdown of academic impact, for papers by Tadayuki Maehara
Rankless by CCL
2026